Company intelligence / Profile preview

Testa Center

Uppsala, Sweden

Ownership: Private
Development stage: Other

Overview

Testa Center is a bioprocess pilot-scale testing and manufacturing facility operated as a non-profit by Cytiva in Uppsala, Sweden, providing researchers and companies with access to integrated bioprocessing laboratories for process development and scale-up of biologics, while allowing full intellectual property retention.

Modalities: Monoclonal antibodyPeptidesProteinVaccineGene therapy
Industry: Contract Manufacturing Organization

Partnerships

Swedish government (co-founder and partial funder through Vinnova)

Beyond the preview

Go deeper on Testa Center.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Testa Center.

Explore the full profile